Poland· PL-100127298
Ambirix
A kombinationen (hepatitis a + hepatitis b) product containing szczepionka (hab) przeciwko wirusowemu zapaleniu wątroby typu a (inaktywowana) i wirusowemu zapaleniu wątroby typu b (rdna), (adsorbowana), registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka (HAB) przeciwko wirusowemu zapaleniu wątroby typu A (inaktywowana) i wirusowemu zapaleniu wątroby typu B (rDNA), (adsorbowana)
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Poland (PL)
- ATC code
- J07BC20
- ATC class
- Kombinationen (Hepatitis A + Hepatitis B)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990008735
- gtin05909990008742
- gtin05909990008759
- gtin05909990008766
- gtin05909990008773
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BC20
Kombinationen (hepatitis a + hepatitis b), as other registers publish it.
- IcelandAmbirixGlaxoSmithKline Biologicals S.A.*
- FinlandAmbirixGlaxoSmithKline Biologicals S.A.
- DenmarkAmbirixGlaxoSmithKline Biologicals S.A.
- BelgiumAmbirixGlaxoSmithKline Biologicals
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/37c740e4-489d-409a-96c6-4461a8ffeb2b GET /v1/drugs/37c740e4-489d-409a-96c6-4461a8ffeb2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "720 j. ELISA + 20 mcg/ml",
"packaging": "05909990008735 ¦ Rp ¦ EU/1/02/224/001 ¦ 24267\n1 amp.-strzyk. 1 ml bez igły\n05909990008742 ¦ Rp ¦ EU/1/02/224/002 ¦ 24268\n1 amp.-strzyk. 1 ml z igłą\n05909990008759 ¦ Rp ¦ EU/1/02/224/003 ¦ 24269\n10 amp.-strzyk. 1 ml bez igły\n05909990008766 ¦ Rp ¦ EU/1/02/224/004 ¦ 24270\n10 amp.-strzyk. 1 ml z igłą\n05909990008773 ¦ Rp ¦ EU/1/02/224/005 ¦ 24271\n50 amp.-strzyk. 1 ml bez igły",
"substance": null,
"common_name": "Szczepionka (HAB) przeciwko wirusowemu zapaleniu wątroby typu A (inaktywowana) i wirusowemu zapaleniu wątroby typu B (rDNA), (adsorbowana)",
"pl_product_id": "100127298",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about kombinationen (hepatitis a + hepatitis b).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.